首页 正文

Peptide-based immunotherapy in lupus: Where are we now?

{{output}}
In autoimmune rheumatic diseases, immune hyperactivity and chronic inflammation associate with immune dysregulation and the breakdown of immune self-tolerance. A continued, unresolved imbalance between effector and regulatory immune responses further exacerbat... ...